Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera

K Mészáros1, S Aberle, M White

  • 1Department of Sepsis Research, XOMA Corporation, Berkeley, California 94710.

Infection and Immunity
|January 1, 1995
PubMed

Insights

Serum

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Lipopolysaccharide (LPS) potentiation by serum relies on LPS-binding protein (LBP) facilitating LPS-CD14 receptor interaction.
  • LPS-binding protein (LBP) is crucial for immune responses to Gram-negative bacteria.

Purpose of the Study:

  • To investigate the heat sensitivity of LBP and serum bioactivity.
  • To assess the impact of heat inactivation on LPS potentiation by serum.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) to measure immunoreactivity.
  • Assay for bioactivity by measuring LPS induction of tumor necrosis factor (TNF) in monocytes.
  • Comparison of human and fetal bovine sera heat sensitivity.

Main Results:

  • Recombinant LBP and various sera exhibited significant heat sensitivity in both immunoreactivity and bioactivity.
  • Human sera demonstrated higher activity and heat sensitivity compared to fetal bovine sera.
  • Standard heat inactivation (56°C, 30 min) of human serum caused a 70% reduction in bioactivity, leading to an apparent decrease in LPS potency.

Conclusions:

  • Standard heat inactivation procedures significantly diminish the bioactivity of serum components involved in LPS potentiation.
  • The heat sensitivity of LBP and serum bioactivity has critical implications for experimental procedures and interpretation of results involving LPS.
  • Researchers should consider the impact of heat inactivation on serum components when designing experiments involving LPS and immune cell activation.

Related Concept Videos